在治疗类风湿关节炎方面追求精准医学
Satoshi Kubo1,2, Yoshiya Tanaka1,2
1Department of Molecular Targeted Therapeutics, University of Occupational and Environmental Health, Kitakyushu, Japan.
精准医学为风湿性关节炎 (RA) 治疗提供了一个有前途的"月球射击". 基于患者分层的定制疗法可以克服当前在实现各种RA病例早期临床缓解方面的挑战.
科学领域:
- 免疫学 免疫学 免疫学
- 类风湿病学 类风湿病学
- 遗传学 是一个遗传学.
背景情况:
- 类风湿性关节炎 (RA) 涉及免疫失调和关节破坏.
- 目前的RA治疗采用了一步一步的方法,使用甲状腺素,生物药物和向合成疾病修饰性抗风湿药物 (DMARDs).
- 由于缺乏可靠的生物标志物,选择最佳治疗仍然存在重大障碍,阻碍了早期临床缓解.
研究的目的:
- 审查复杂的类风湿性关节炎 (RA) 的发病过程.
- 突出需要精准医学来解决RA的异质性.
- 强调准确的患者分层,以优化向治疗.
主要方法:
- 审查了解RA病变的最新科学和技术进步.
- 对不同表型子组的患者分层方法的分析.
- 讨论临床试验中的挑战和成本效益.
主要成果:
- 最近的进展揭示了RA的发病因子,使患者的分层成为可能.
- 分层化有可能优化向治疗选择.
- 关于成本,物流和大规模试验的挑战仍然存在.
结论:
- 通过精准医学解决类风湿性关节炎 (RA) 异质性至关重要.
- 进一步调查RA病变的遗传和环境因素是必不可少的.
- 准确的精准医学患者分层应该被追求作为一个"月球"目标转型性RA治疗的突破.
更多相关视频
07:44Author Spotlight: Implementation of BIVA for Analyzing Disease Risk Factors in Patients with Low Body Cell Mass
Published on: July 14, 2023
11:03A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model
Published on: October 30, 2019
相关概念视频
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
The JAK-STAT Signaling Pathway
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
